Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

Zynext Ventures USA LLC (Zynext), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Agenus Inc., a leading US-based immuno-oncology company developing ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, ...

Diagens has developed the Rapid AI karyotype total solution based on iMedImage ®, a globally leading general medical imaging ...

Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38th annual meeting of ...

The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, was featured in a poster ...

Global pharma major Lupin Limited (Lupin) will present data from its Phase 1a clinical trial evaluating LNP7457, a PRMT5 inhibitor, at the American Society of Clinical Oncology (ASCO) annual meeting ...

Data presented by Delix Therapeutics at the 2025 American Society of Clinical Psychopharmacology (ASCP) Conference confirms the NeuLogiq® Platform is effective at detecting a pharmacodynamic ...

attend symposia or walk round viewing medical posters. All of this can be translated to online media – articles, video, webinars, infographics etc. Assimilation is much more complex. This is ...

The Ariel Helwani ShowEverything boxing & MMA from the world and mind of Ariel Helwani. The Kevin O'Connor ShowKevin O'Connor talks ball with the best names from around the world of basketball ...

A major new campaign funded by BT and Virgin Media and backed by the UK Government has launched, urging the millions of ...